# US 2026/0097073 A1 · Process for the preparation of tungsten (vi) salt hydrates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0097073 A1
- Document ID: US20260097073A1
- Status: Published application
- Kind: A1
- Application number: 19/128,288
- Filed: 2023-11-08
- Published: 2026-04-09
- Earliest claimed: 2022-11-08
- Assignees: Oxolife, S.L.
- Applicants: Oxolife, S.L.
- Inventors: Agnès Arbat Bugié; Rosa Torres Ferraz; Jordi Bessa Bellmunt; Abel Tamayo Haro; Ignacio Canals Almazán
- Web page: https://patentgrep.com/patent/US20260097073A1

## CPC

- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- C01G 41/00: Compounds of tungsten
- C01P 2002/82: by IR- or Raman-data
- C01P 2006/80: Compositional purity
- C01P 2006/82: water content
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C01G: COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F (metal hydrides {monoborane, diborane or addition complexes thereof} C01B6/00; salts of oxyacids of halogens C01B11/00; peroxides, salts or peroxyacids C01B15/00; thiosulfates, dithionites, polythionates C01B17/64; compounds containing selenium, or tellurium C01B19/00; binary compounds of nitrogen with metals C01B21/06; azides C01B21/08; {compounds containing nitrogen, other non-metals and metal C01B21/082}; metal amides C01B21/092; nitrites C01B21/50; {compounds of noble gases C01B23/0005}; phosphides C01B25/08; salts of oxyacids of phosphorus C01B25/16; carbides C01B32/90; compounds containing silicon C01B33/00; compounds containing boron C01B35/00; compounds having molecular sieve properties but not having base-exchange properties C01B37/00; compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites, C01B39/00; cyanides C01C3/08; salts of cyanamide C01C3/16; thiocyanates C01C3/20)
- C01P: INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS

## Abstract

The present invention provides a process for preparing tungsten (VI) salts hydrates, the process comprising (a) Preparing a tungsten (VI) salt in an alkaline aqueous solution; (b) Filtering the aqueous solution at a temperature at which the tungsten (VI) salt remains dissolved; (c) Precipitating the tungsten (VI) salt hydrate from the filtrate resulting from step (b); (d) Filtering; (e) Washing the resulting filter cake with a water-miscible solvent; and (f) Drying the washed cake under conditions that allow the removal of the water-miscible solvent. The resulting salts show a level of impurities and solvents so low that they are suitable in the fields of pharmacy, veterinary and dietary.

## Claims

### Claim 1

A process for obtaining a tungsten (VI) salt hydrate, the process comprising:
(a) Preparing a tungsten (VI) salt in an alkaline aqueous solution;
(b) Filtering the aqueous solution at a temperature at which the tungsten (VI) salt remains dissolved;
(c) Precipitating the tungsten (VI) salt hydrate from the filtrate resulting from step (b), at a temperature below 100° C., particularly below 50° C.;
(d) Filtering the precipitated salt;
(e) Washing the resulting filter cake with a water-miscible solvent; and
(f) Drying the washed cake under conditions that allow the removal of the water-miscible solvent.

### Claim 2 (depends on 1)

The process of claim 1, wherein the tungsten (VI) salt hydrate comprises an anion selected from the group consisting of tungstate and isopolytungstate, particularly the anion is tungstate.

### Claim 3

The process according to any one of the preceding claims, wherein the tungsten (VI) salt hydrate comprises a cationic moiety selected from the group of cations: sodium, ammonium, potassium, magnesium, and calcium, zinc, copper, and silver.

### Claim 4

The process of any one of the preceding claims, wherein the tungsten (VI) salt hydrate is dihydrate sodium tungstate.

### Claim 5

The process of any one of the preceding claims, wherein step (a) is performed by dissolving a tungsten-containing compound selected from: WO3, a paratungstate salt, and tungstic acid, in an alkaline aqueous solution.

### Claim 6

The process of any one of the preceding claims, wherein the alkaline aqueous solution further includes cationic moieties selected from sodium, ammonium, copper, potassium, magnesium, and calcium, zinc and silver.

### Claim 7 (depends on 5, 6)

The process of any one of the preceding claims 5-6, wherein the alkaline aqueous solution is added in a molar excess with respect to the tungsten-containing compound.

### Claim 8

The process of any one of the preceding claims, wherein step (a) is performed by heating to a temperature lower than the reflux temperature.

### Claim 9

The process of any one of the preceding claims, wherein the filtering step (b) is performed at a temperature equal or above 30° C. but below the reflux temperature.

### Claim 10

The process of any one of the preceding claims, wherein step (c) is performed by cooling or adding a water-miscible solvent.

### Claim 11

The process of any one of the preceding claims, wherein the water-miscible solvent used in steps (c) and (e) comprises or consists (C1-C8)alkanol.

### Claim 12

The process of any one of the preceding claims, wherein step (e) is repeated.

### Claim 13

The process of any one of the preceding claims for obtaining Na2WO4·2H2O, the process comprising:
(i) Preparing the tungsten (VI) salt in an alkaline aqueous solution by dissolving the tungsten-containing compound selected from WO3, a paratungstate salt or tungstic acid in a sodium alkaline aqueous solution at a temperature from 30 to 95° C.;
(ii) Filtering the aqueous solution at a temperature from 30 to 60° C.;
(iii) Precipitating the dihydrate tungsten (VI) salt from the filtrate resulting from step (b1) by adding a water/miscible solvent comprising or consisting of (C1-C8)alkanol;
(iv) Filtering the precipitated salt;
(v) Washing the resulting filter cake with a water-miscible solvent comprising or consisting of (C1-C8)alkanol; and
(vi) Drying at a temperature below 50° C., particularly from 15 to 25° C., particularly from 18 to 22° C.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The process of any one of claims 1 to 12 for obtaining Na2WO4·2H2O, the process comprising:
(a1) Preparing the tungsten (VI) salt in an alkaline aqueous solution by dissolving WO3 in a sodium alkaline aqueous solution at a temperature from 80 to 95° C.;
(b1) Filtering the aqueous solution at a temperature from 50 to 90° C.;
(c1) Precipitating the dihydrate tungsten (VI) salt from the filtrate resulting from step (b1) by adding a water/miscible solvent comprising or consisting of (C1-C8)alkanol;
(d1) Filtering the precipitated salt;
(e1) Washing the resulting filter cake with a water-miscible solvent comprising or consisting of (C1-C8)alkanol; and
(f1) Drying at a temperature from 18 to 22° C.; or, alternatively,
the process comprising:
(a2) Preparing the tungsten (VI) salt in an alkaline aqueous solution by dissolving APT in a sodium alkaline aqueous solution at a temperature from 50 to 70° C.;
(b2) Filtering the aqueous solution at a temperature from 35 to 60° C.;
(c2) Precipitating the dihydrate tungsten (VI) salt from the filtrate resulting from step (b2) by adding a water-miscible solvent comprising or consisting of (C1-C8)alkanol;
(d2) Filtering the precipitated salt;
(e2) Washing the resulting filter cake with a water-miscible solvent comprising or consisting of (C1-C8)alkanol; and
(f2) Drying at a temperature from 18 to 22° C.; or, alternatively,
the process comprising:
(a3) Preparing the tungsten (VI) salt in an alkaline aqueous solution by dissolving H2WO4 in a sodium alkaline aqueous solution at a temperature below 40° C.;
(b3) Filtering the aqueous solution at a temperature from 30 to 60° C., particularly from 35 to 45° C., particularly 35° C.;
(c3) Precipitating the dihydrate tungsten (VI) salt from the filtrate resulting from step (b3) by adding a water-miscible solvent comprising or consisting of (C1-C8)alkanol;
(d3) Filtering the precipitated salt;
(e3) Washing the resulting filter cake with a water-miscible solvent comprising or consisting of (C1-C8)alkanol; and
(f3) Drying at a temperature below 50, below 49, below 48, below 47, below 46, below 45, below 44, below 43, below 42, below 41, below 40, below 39, below 38, below 37, below 36, below 35, below 34, below 33, below 32, below 31, below 30, below 29, below 28, below 27, below 26, below 25, below 24, below 23, below 22, below 21 or below 20° C.; particularly at a temperature from 18 to 22° C.

### Claim 15

A pharmaceutical, veterinary or dietary sodium tungstate dihydrate comprising a water residual content from 10 to 15% by weight with respect to the total weight of the salt.

### Claim 16 (depends on 15)

A pharmaceutical or veterinary or food composition comprising a therapeutically effective amount of the sodium tungstate dihydrate as defined in claim 15, together with one or more pharmaceutically or veterinarily or dietary acceptable excipients or carriers.

### Claim 17 (depends on 15)

A sodium tungstate dihydrate as defined in claim 15 for use in therapy.

### Claim 18 (depends on 15)

A sodium tungstate dihydrate as defined in claim 15 for use in the treatment of female infertility.
